REFERENCES
  1. Piret J, Boivin G. Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance. Antiviral Res. 2019;163:91-105. doi: 10.1016/j.antiviral.2019.01.011.
  2. Marty FM, Ljungman P, Chemaly RF, et al. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation. N Engl J Med . 2017;377(25):2433-2444. doi: 10.1056/NEJMoa1706640.
  3. Cassaniti I, Colombo AA, Bernasconi P, et al. Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection. Am J Transplant . 2021; 21(4):1622-1628. doi: 10.1111/ajt.16450.
  4. Tong Y, Pang XL, Mabilangan C, et al. Determination of the Biological Form of Human Cytomegalovirus DNA in the Plasma of Solid-Organ Transplant Recipients. J Infect Dis . 2017; 215(7):1094-1101. doi: 10.1093/infdis/jix069.
  5. Gerna G, Baldanti F, Lilleri D, et al. Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial. Transplantation . 2003;75(7):1012-1019. doi: 10.1097/01.TP.0000057239.32192.B9.
  6. Gerna G, Lilleri D, Baldanti F, et al. Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial. Blood . 2003;101(12):5053-5060. doi: 10.1182/blood-2002-12-3636.
  7. Lehto JT, Lemström K, Halme M, et al A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.Transpl Int . 2005;18(12):1318-1327. doi: 10.1111/j.1432-2277.2005.00226.x.
  8. Terhune SS, Schröer J, Shenk T. RNAs are packaged into human cytomegalovirus virions in proportion to their intracellular concentration. J Virol . 2004;78(19):10390-10398. doi: 10.1128/JVI.78.19.10390-10398.2004.
  9. Gerna G, Vitulo P, Rovida F, et al. Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients.J Med Virol . 2006;78(3):408-416. doi: 10.1002/jmv.20555. Erratum in: J Med Virol . 2008;80(10):1869.
  10. Furione M, Rognoni V, Cabano E, et al. Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay. J Clin Virol . 2012;55(4):317-322. doi: 10.1016/j.jcv.2012.08.017.
  11. Wu Z, Ren X, Yang L, et al. Virome analysis for identification of novel mammalian viruses in bat species from Chinese provinces. J Virol . 2012;86(20):10999-11012. doi: 10.1128/JVI.01394-12.
  12. Gerna G, Revello MG, Percivalle E, et al. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. J Clin Microbiol 1990;28: 2681-8.
  13. Gerna G, Zavattoni M, Baldanti F, et al. Human cytomegalovirus (HCMV) leukodnaemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection. Transplantation . 1998;65(10):1378-85. doi: 10.1097/00007890-199805270-00016.
  14. Gerna G, Lilleri D, Zecca M, et al. Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.Haematologica . 2005;90(4):526-533.
  15. Baldanti F, Lilleri D, Gerna G. Monitoring human cytomegalovirus infection in transplant recipients. J Clin Virol . 2008;41(3):237-241. doi: 10.1016/j.jcv.2007.12.001.
  16. Kotton CN, Kumar D, Caliendo AM, et al; The Transplantation Society International CMV Consensus Group. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation. Transplantation . 2018;102(6):900-931. doi: 10.1097/TP.0000000000002191.
  17. Gerna G, Sarasini A, Lilleri D, et al. In vitro model for the study of the dissociation of increasing antigenemia and decreasing DNAemia and viremia during treatment of human cytomegalovirus infection with ganciclovir in transplant recipients. J Infect Dis . 2003;188(11):1639-1647. doi: 10.1086/379376.
  18. Chou S, Satterwhite LE, Ercolani RJ. New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by In Vitro Exposure to Letermovir and Ganciclovir. Antimicrob Agents Chemother. 2018;62(9):e00922-18. doi: 10.1128/AAC.00922-18.
  19. Biron KK, Harvey RJ, Chamberlain SC, et al. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.Antimicrob Agents Chemother . 2002;46(8):2365-2372. doi: 10.1128/AAC.46.8.2365-2372.2002.
  20. Maertens J, Cordonnier C, Jaksch P, et al. Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation. N Engl J Med . 2019(12);381:1136-1147. doi: 10.1056/NEJMoa1714656.
  21. Bresnahan WA, Shenk T. A subset of viral transcripts packaged within human cytomegalovirus particles. Science . 2000;288(5475):2373-2376. doi: 10.1126/science.288.5475.2373
  22. Greijer AE, Dekkers CA, Middeldorp JM. Human cytomegalovirus virions differentially incorporate viral and host cell RNA during the assembly process. J Virol . 2000;74(19):9078-9082. doi: 10.1128/jvi.74.19.9078-9082.2000.
  23. Sarcinella E, Brown M, Tellier R, et al. Detection of RNA in purified cytomegalovirus virions. Virus Res . 2004;104(2):129-137. doi: 10.1016/j.virusres.2004.03.008.
  24. Sciortino MT, Suzuki M, Taddeo B, et al. RNAs extracted from herpes simplex virus 1 virions: apparent selectivity of viral but not cellular RNAs packaged in virions. J Virol . 2001;75(17):8105-8116. doi: 10.1128/jvi.75.17.8105-8116.2001.
  25. Boriskin YS, Fuller K, Powles RL, et al. Early detection of cytomegalovirus (CMV) infection in bone marrow transplant patients by reverse transcription-PCR for CMV spliced late gene UL21.5: a two site evaluation. J Clin Virol . 2002(1-2);24:13-23. doi: 10.1016/s1386-6532(01)00209-8.
  26. Gerna G, Percivalle E, Baldanti F, et al. Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events.J Virol . 2000;74(12):5629-5638. doi: 10.1128/jvi.74.12.5629-5638.2000.
  27. Piccirilli G, Lanna F, Gabrielli L, et al. CMV-RNAemia as new marker of active viral replication in transplant recipients. J Clin Microbiol . 2024;62(5):e0163023. doi: 10.1128/jcm.01630-23.
  28. Blank A, Dekker CA. Ribonucleases of human serum, urine, cerebrospinal fluid, and leukocytes. Activity staining following electrophoresis in sodium dodecyl sulfate-polyacrylamide gels. Biochemistry . 1981;20(8):2261-2267. doi: 10.1021/bi00511a030.
  29. Girmenia C, Lazzarotto T, Bonifazi F, et al. Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies.Clin Transplant . 2019;33(10):e13666. doi: 10.1111/ctr.13666.
TABLE 1. Characteristics of the patients analysed.